Product Description: Pemedolac (AY-30715) is a potent analgesic with significant pain-relief efficacy against chemically induced and inflammatory pain in animal models. Pemedolac displays a notable separation between analgesic effects and anti-inflammatory activity, achieving effective pain relief at much lower doses than those required for anti-inflammatory or gastric irritant effects. Pemedolac also shows low ulcerogenic potential, indicating a safer profile compared to standard NSAIDs while being utilized for the treatment of neurological, skin, and musculoskeletal disorders.
Applications: COVID-19-immunoregulation
Formula: C22H23NO3
References: [1]Pemedolac: a novel and long-acting non-narcotic analgesic
CAS Number: 114716-16-4
Molecular Weight: 349.42
Research Area: Inflammation/Immunology
Target: COX